DK320686A - Ekspressionskontrolsekvenser - Google Patents

Ekspressionskontrolsekvenser Download PDF

Info

Publication number
DK320686A
DK320686A DK320686A DK320686A DK320686A DK 320686 A DK320686 A DK 320686A DK 320686 A DK320686 A DK 320686A DK 320686 A DK320686 A DK 320686A DK 320686 A DK320686 A DK 320686A
Authority
DK
Denmark
Prior art keywords
gram
expression control
expression
dna sequences
positive
Prior art date
Application number
DK320686A
Other languages
English (en)
Other versions
DK320686D0 (da
DK175206B1 (da
Inventor
Hermann Bujard
Stuart Le Grice
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK320686D0 publication Critical patent/DK320686D0/da
Publication of DK320686A publication Critical patent/DK320686A/da
Application granted granted Critical
Publication of DK175206B1 publication Critical patent/DK175206B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198603206A 1985-07-05 1986-07-04 Ekspressionskontrolsekvenser DK175206B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858517071A GB8517071D0 (en) 1985-07-05 1985-07-05 Gram-positive expression control sequence
GB8517071 1985-07-05

Publications (3)

Publication Number Publication Date
DK320686D0 DK320686D0 (da) 1986-07-04
DK320686A true DK320686A (da) 1987-01-06
DK175206B1 DK175206B1 (da) 2004-07-12

Family

ID=10581857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198603206A DK175206B1 (da) 1985-07-05 1986-07-04 Ekspressionskontrolsekvenser

Country Status (12)

Country Link
US (1) US4868111A (da)
EP (1) EP0207459B1 (da)
JP (2) JP2632809B2 (da)
AT (1) ATE62020T1 (da)
AU (1) AU594349B2 (da)
CA (1) CA1316850C (da)
DE (1) DE3678343D1 (da)
DK (1) DK175206B1 (da)
GB (1) GB8517071D0 (da)
IE (1) IE59165B1 (da)
IL (1) IL79291A (da)
NZ (1) NZ216688A (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266474A (en) * 1987-06-24 1993-11-30 Genentech, Inc. Balanced inducible transcription system
DE3853932D1 (de) * 1987-08-17 1995-07-13 Hoffmann La Roche Hochreprimierbare Expressionskontrollsequenzen.
US5726042A (en) * 1988-04-07 1998-03-10 Abbott Laboratories Expression of heterologous proteins in Bacillus megaterium utilizing sporulation promoters of Bacillus subtilis
GB8811761D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Biosynthetic process for preparation of chemical compounds
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
FR2679568B1 (fr) * 1991-07-22 1994-09-02 Pasteur Institut Nouveau type de replicon gram-positif - construction de vecteurs recombinants le contenant.
CA2130453A1 (en) 1992-02-27 1993-09-02 Richard W. F. Le Page Heterologous gene expression in lactococcus, and the expression products threrefrom
US6022730A (en) * 1994-06-17 2000-02-08 Robinson; Douglas H. Methods for the isolation of bacteria containing eukaryotic genes
US5629205A (en) * 1995-05-19 1997-05-13 Allelix Biopharmaceuticals Inc. Promoters for gene expression
US6194168B1 (en) * 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
US6146848A (en) * 1998-07-23 2000-11-14 The Hong Kong University Of Science & Technology Bacterial expression system
US6720174B1 (en) 1999-01-28 2004-04-13 Novozymes A/S Phytases
WO2000061762A1 (en) * 1999-04-09 2000-10-19 Techlab, Inc. RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
EP1201767B1 (en) * 2000-10-25 2010-07-21 FUJIFILM Corporation Method of analyzing double stranded DNA
JP2005523000A (ja) * 2001-10-26 2005-08-04 アイディー バイオメディカル コーポレイション オブ ワシントン 多価連鎖球菌性ワクチン組成物および使用方法
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
AU2004293810B2 (en) 2003-11-19 2010-07-01 Pelican Technology Holdings, Inc. Improved protein expression systems
EP2336153B1 (en) 2003-11-21 2016-03-30 Pfenex Inc. Improved expression systems with SEC-system secretion
JP5602336B2 (ja) 2004-01-16 2014-10-08 フェネックス インコーポレイテッド シュードモナス・フルオレッセンスにおける哺乳動物タンパク質の発現
WO2006014899A2 (en) 2004-07-26 2006-02-09 Dow Global Technologies Inc. Process for improved protein expression by strain engineering
GB0602173D0 (en) * 2006-02-03 2006-03-15 Avecia Ltd Expression system
WO2008047364A2 (en) * 2006-10-18 2008-04-24 Periness Ltd. Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
PL2468869T3 (pl) 2007-01-31 2015-08-31 Pfenex Inc Bakteryjna sekwencja wiodąca dla zwiększonej ekspresji
AU2008245696B2 (en) 2007-04-27 2013-11-07 Pelican Technology Holdings, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
ES2640947T3 (es) 2009-05-11 2017-11-07 Pfenex, Inc. Producción de proteínas recombinantes utilizando métodos de selección no antibióticos y la incorporación de aminoácidos no naturales en las mismas
CN102906108B (zh) 2010-03-04 2016-01-20 菲尼克斯公司 用于无变性制备可溶性重组干扰素蛋白的方法
CA2793978C (en) 2010-03-30 2021-08-03 Pfenex Inc. High level expression of recombinant toxin proteins
PL2552949T3 (pl) 2010-04-01 2017-01-31 Pfenex Inc. Sposoby wytwarzania G-CSF w komórce gospodarza Pseudomonas
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US11408007B2 (en) 2014-09-26 2022-08-09 Yale University Compositions and methods for biocontainment of microorganisms
BR112017011662A2 (pt) 2014-12-01 2018-02-27 Pfenex Inc parceiros de fusão para a produção de peptídeo
EP3700915A4 (en) 2017-10-27 2021-07-28 Pfenex Inc. GUIDED BACTERIAL SEQUENCES FOR THE EXPRESSION OF PERPLASMIC PROTEINS
CN111278852A (zh) 2017-10-27 2020-06-12 菲尼克斯公司 重组欧氏杆菌天冬酰胺酶的生产方法
US11149280B2 (en) 2019-10-29 2021-10-19 Yale University Engineering organisms resistant to viruses and horizontally transferred genetic elements
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
WO2023178316A2 (en) 2022-03-17 2023-09-21 Yale University Compositions and methods for expressing synthetic genetic elements across diverse microorganisms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495280A (en) * 1981-05-20 1985-01-22 The Board Of Trustees Of The Leland Stanford Jr. University Cloned high signal strength promoters
GR81701B (da) 1983-01-18 1984-12-12 Lilly Co Eli
EP0115936A1 (en) * 1983-01-24 1984-08-15 Kabushiki Kaisha Yakult Honsha Chimeric plasmids

Also Published As

Publication number Publication date
GB8517071D0 (en) 1985-08-14
NZ216688A (en) 1990-06-26
EP0207459A3 (en) 1988-07-06
AU5938586A (en) 1987-01-08
DE3678343D1 (de) 1991-05-02
EP0207459A2 (en) 1987-01-07
JP2887248B2 (ja) 1999-04-26
IL79291A0 (en) 1986-09-30
JPS6214786A (ja) 1987-01-23
IL79291A (en) 1991-06-30
CA1316850C (en) 1993-04-27
IE59165B1 (en) 1994-01-12
IE861806L (en) 1987-01-05
JP2632809B2 (ja) 1997-07-23
US4868111A (en) 1989-09-19
DK320686D0 (da) 1986-07-04
DK175206B1 (da) 2004-07-12
EP0207459B1 (en) 1991-03-27
ATE62020T1 (de) 1991-04-15
AU594349B2 (en) 1990-03-08
JPH10229878A (ja) 1998-09-02

Similar Documents

Publication Publication Date Title
DK320686D0 (da) Ekspressionskontrolsekvenser
MX428A (es) Region regulatoria para expresion de gen heterologa en levadura.
HK1013847A1 (en) Gdf-1 and uog-1 proteins
EP0048970A3 (en) Polypeptides, process for their microbial production, intermediates therefor and compositions containing them
ES8305413A1 (es) Un metodo para estabilizar y seleccionar celulas huesped quecontienen un adn recombinante
ES552431A0 (es) Procedimiento para preparar plasmidos de expresion prhw11 y prhw12
GR3006248T3 (da)
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
AU592791B2 (en) Recombinant DNA expression vectors and DNA compounds which encode isopenicillin N synthetase
AU6989687A (en) Preparation of factor XIIIa by gene manipulation
DK509886A (da) Udtrykkelsesforoegende dna-sekvenser
ES2100953T3 (es) Expresion en lineas linfoblastoides humanas no tumorales con un vector integrante.
AU589151B2 (en) New expression control sequence
DE3751757T2 (de) Autonom replizierende DNA Fragmente aus Säugerzellen mit Affinität zu DNA bindenden Proteinen
TW342413B (en) Novel toxins isolated from Bracon Hebetor

Legal Events

Date Code Title Description
PUP Patent expired